Barclays »

X4 Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $230k 58k 4.00

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corp Opt Put Option (MSFT)
Apple (AAPL)
Ishares Tr Opt Call Option (IWM)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
Facebook Inc cl a (META)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Opt Put Option (HYG)
Advanced Micro Devices (AMD)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding X4 Pharmaceuticals

Empery Asset Management
Bain Capital Life Sciences Investors
Saturn V Capital Management
Deep Track Capital
Vanguard Group
Braidwell
Rosalind Advisors
Nantahala Capital Management
BVF
Samsara BioCapital
Siren
BlackRock
Woodline Partners
Geode Capital Management
Kingdon Capital Management

View all funds holding X4 Pharmaceuticals